1983
DOI: 10.1016/0008-8749(83)90097-7
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of antibody-mediated inhibition of natural killer (NK) cytotoxicity: Evidence for blocking of both recognition and lethal hit stages of cytolysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1983
1983
1989
1989

Publication Types

Select...
3
3

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 17 publications
0
4
0
Order By: Relevance
“…In subsequent experiments using different batches of RAT* sera the blocking activity was similar to that seen with EGTA, i.e. restricted to the early stage of programming (Figure 3, Kahle et al 1983).…”
Section: Involvement Of Gp 95 Gp 140 Gp 180 In the Lethal Hit Smentioning
confidence: 55%
See 2 more Smart Citations
“…In subsequent experiments using different batches of RAT* sera the blocking activity was similar to that seen with EGTA, i.e. restricted to the early stage of programming (Figure 3, Kahle et al 1983).…”
Section: Involvement Of Gp 95 Gp 140 Gp 180 In the Lethal Hit Smentioning
confidence: 55%
“…The results showed that RAT* IgG block NK targetconjugate formation. In addition, using the Ca^* pulse experiment, we saw that, similar to the effects seen with CTL (Kahle et al 1983), RAT* was capable of blocking the lethal hit event. Also noteworthy is our demonstration that RAT* also blocks cytotoxic factors derived from NK cells (Wright et al 1981), Taken together, these results suggest that RAT* recognizes membrane antigens or cell-free-extracts involved in the lethal hit event in both NK and CTL cytotoxic systems.…”
Section: Rat* Reveals That Ctl and Nk Cytotoxicity Share A Common Patmentioning
confidence: 69%
See 1 more Smart Citation
“…The results suggest that these antibodies interfere with a post-binding step of the cytotoxic reaction. This distinguishes our mAb from other antibodies previously reported to inhibit NK by interfering with lymphocyte-target cell binding [22,25,56). On the other hand, Martz [16] and Neville and Hiserodt [17] have described antibodies that block cytotoxicity by human NK cells at a post-binding stage.…”
Section: Discussionmentioning
confidence: 78%